Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets

Clinical trial NCT00536796 · COMPLETED

Trial details

NCT number: NCT00536796
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Hyperlipidemias Atherosclerosis Coronary Heart Disease Carotid Stenosis Peripheral Vascular Diseases Diabetes Mellitus

Start date: 2007-09-01
Primary completion: 2007-12-01
Enrollment: 1096

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.